Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 5mg | $30.00 | $6.00/mg | In stock | Jul 4 |
| vial | 10mg | $55.00 | $5.50/mg | In stock | Jul 4 |
| vial | 5mg | $84.00 | $16.80/mg | In stock | Jul 4 |
| vial | 5mg | $120.00 | $24.00/mg | In stock | Jul 4 |
| vial | 10mg | $150.00 | $15.00/mg | In stock | Jul 4 |
| vial | 5mg | $205.00 | $41.00/mg |
| Lot / Report | Tested | Purity | Lab | Panels | Status | |
|---|---|---|---|---|---|---|
| CWD05192026 | May 2026 | 99.8% | Freedom Diagnostics | Endotoxin | Confirmed | View |
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. CJC-1295 is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does Peptide Supply Co. sell CJC-1295?
Yes — Peptide Supply Co. currently lists CJC-1295 in 8 variants starting at $55.00 ($5.50/mg).
Is Peptide Supply Co.'s CJC-1295 third-party tested?
Yes — Disclosed Labs has indexed 4 Certificates of Analysis for Peptide Supply Co.'s CJC-1295, with the most recent showing 99.8% purity. Peptide Supply Co. holds an overall trust grade of B (81/100) across all 137 COAs on file.
What is Peptide Supply Co.'s trust grade for CJC-1295?
Peptide Supply Co. has an overall Disclosed Labs trust grade of B (81/100), computed from 137 COAs across all peptides. The most recent CJC-1295 COA was issued by Freedom Diagnostics.
Where is the cheapest CJC-1295?
As of the latest data, Peptide Partners offers CJC-1295 at $3.33/mg — compare with Peptide Supply Co.'s listing at $5.50/mg. See the full CJC-1295 price comparison.
Is CJC-1295 legal to buy?
CJC-1295 is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| Jul 4 |
| vial | 10mg | $225.00 | $22.50/mg | In stock | Jul 4 |
| vial | 10mg | $380.00 | $38.00/mg | In stock | Jul 4 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
| CJC05192026 | May 2026 | 99.8% | Freedom Diagnostics | Endotoxin | Confirmed | View |
| CD503232026 | Mar 2026 | 99.6% | Freedom Diagnostics | Endotoxin | Confirmed | View |
| CJCND10031026 | Mar 2026 | 99.9% | Freedom Diagnostics | — | Confirmed | View |